Login / Signup

Cannabidiol inhibits Na v channels through two distinct binding sites.

Jian HuangXiao FanXueqin JinSooyeon JoHanxiong Bear ZhangAkie FujitaBruce P BeanNieng Yan
Published in: Nature communications (2023)
Cannabidiol (CBD), a major non-psychoactive phytocannabinoid in cannabis, is an effective treatment for some forms of epilepsy and pain. At high concentrations, CBD interacts with a huge variety of proteins, but which targets are most relevant for clinical actions is still unclear. Here we show that CBD interacts with Na v 1.7 channels at sub-micromolar concentrations in a state-dependent manner. Electrophysiological experiments show that CBD binds to the inactivated state of Na v 1.7 channels with a dissociation constant of about 50 nM. The cryo-EM structure of CBD bound to Na v 1.7 channels reveals two distinct binding sites. One is in the IV-I fenestration near the upper pore. The other binding site is directly next to the inactivated "wedged" position of the Ile/Phe/Met (IFM) motif on the short linker between repeats III and IV, which mediates fast inactivation. Consistent with producing a direct stabilization of the inactivated state, mutating residues in this binding site greatly reduced state-dependent binding of CBD. The identification of this binding site may enable design of compounds with improved properties compared to CBD itself.
Keyphrases
  • chronic pain
  • binding protein
  • photodynamic therapy
  • pain management
  • neuropathic pain
  • smoking cessation
  • tyrosine kinase